Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutrafol Men 50+
- Development stage
- Unknown
- Lead developer
- Nutraceutical Wellness
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Nutrafol Men 50+ is a physician-formulated, 100% drug-free, vegan daily nutraceutical developed by Nutrafol. It is specifically designed for men aged 50 and older to address age-related hair thinning by targeting root causes such as hormonal changes (specifically DHT), stress, cellular aging, and metabolic shifts. The supplement features the patented Synergen Complex Renewal blend, which includes botanical extracts like Saw Palmetto, Sensoril Ashwagandha, and Turmeric, alongside the probiotic *Bacillus subtilis* DE111 and spermidine. It aims to improve hair growth, thickness, and scalp coverage without affecting sexual performance.
- Brand names
- Nutrafol Men 50+
02
Targets
SRD5A (Steroid 5-alpha-reductase)AR (Adrenergic receptors)
Beyond the preview
Go deeper on Nutrafol Men 50+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nutrafol Men 50+.